These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 35905891)

  • 1. Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis.
    Li X; Li Q; Xiong B; Chen H; Wang X; Zhang D
    Pharmacol Res; 2022 Sep; 183():106368. PubMed ID: 35905891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
    Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
    Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
    Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
    BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Expression of Cystathionine β-Synthase Exacerbates Intestinal Barrier Injury in Ulcerative Colitis.
    Chen S; Zuo S; Zhu J; Yue T; Bu D; Wang X; Wang P; Pan Y; Liu Y
    J Crohns Colitis; 2019 Aug; 13(8):1067-1080. PubMed ID: 30722010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
    Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
    Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response.
    Wang Y; Liu J; Huang Z; Li Y; Liang Y; Luo C; Ni C; Xie J; Su Z; Chen J; Li C
    Eur J Pharmacol; 2021 Apr; 896():173912. PubMed ID: 33508280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effects of the p38 mitogen-activated protein kinase-myosin light chain kinase pathway on the intestinal epithelial mechanical barrier and the mechanism of modified Pulsatilla decoction in the treatment of ulcerative colitis.
    Tingting WU; Xin Y; Huiping Z; Jinwei G; Hui Z; Peipei Z; Meng W; Guoqiang L; Hongwen S
    J Tradit Chin Med; 2024 Oct; 44(5):885-895. PubMed ID: 39380219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Lizhong decoction on ulcerative colitis in mice by suppressing inflammation and ameliorating gut barrier.
    Shen Y; Zou J; Chen M; Zhang Z; Liu C; Jiang S; Qian D; Duan JA
    J Ethnopharmacol; 2020 Sep; 259():112919. PubMed ID: 32360800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
    Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
    Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice.
    Yu XT; Xu YF; Huang YF; Qu C; Xu LQ; Su ZR; Zeng HF; Zheng L; Yi TG; Li HL; Chen JP; Zhang XJ
    PLoS One; 2018; 13(3):e0194069. PubMed ID: 29538417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC26A3 (DRA) prevents TNF-alpha-induced barrier dysfunction and dextran sulfate sodium-induced acute colitis.
    Ding X; Li D; Li M; Wang H; He Q; Wang Y; Yu H; Tian D; Yu Q
    Lab Invest; 2018 Apr; 98(4):462-476. PubMed ID: 29330471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1/AKT/NF-κB signaling pathway.
    Yao L; Chen X; Shen M; Zhao Y; Cao Q
    Int Immunopharmacol; 2023 Jan; 114():109532. PubMed ID: 36508925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies.
    Raj V; Venkataraman B; Ojha SK; Almarzooqi S; Subramanian VS; Al-Ramadi BK; Adrian TE; Subramanya SB
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine alleviates intestinal barrier dysfunction and inflammatory response in mice via suppressing TLR4/MyD88/NF-κB signaling in an experimental model of ulcerative colitis.
    Ye X; Xu H; Xu Y
    Folia Histochem Cytobiol; 2022; 60(4):311-322. PubMed ID: 36504132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO‑1 pathway activity: Integrating animal experiments and network pharmacology.
    Yu X; Li X; Xu Y; Li Y; Zhou Y; Zhang J; Guo L
    Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HO-1/CO Maintains Intestinal Barrier Integrity through NF-
    Zhang Z; Zhang L; Zhang Q; Liu B; Li F; Xin Y; Duan Z
    Oxid Med Cell Longev; 2021; 2021():6620873. PubMed ID: 34104309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin alleviates ulcerative colitis through SHP-1/STAT3 pathway.
    Li BL; Zhao DY; Du PL; Wang XT; Yang Q; Cai YR
    Inflamm Res; 2021 Jun; 70(6):705-717. PubMed ID: 34014331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin promotes the intestinal barrier repair in ulcerative colitis via the mTOR/PBLD/AMOT signaling pathway.
    Xu Y; Ou J; Zhang C; Chen J; Chen J; Li A; Huang B; Zhao X
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167287. PubMed ID: 38862095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.